Sun Pharma Advanced Research Company Ltd share price logo

Sparc Share Price

NSE: SPARC

BSE: 532872

Small Cap

Healthcare Sector

144.25

-0.05

(-0.03%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Sparc Stock Performance

as on September 18, 2025 at 3:17 pm IST

  • Day's Low

    Day's High

    ₹143.11
    ₹146.9
    downward going graph

    0.79%

    Downside

    1.84%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    ₹109.3
    ₹241
    downward going graph

    24.23%

    Downside

    67.07%

    Upside

    downward going graph

Sparc share price movements today

Previous Close
₹144.30
Open
₹144.25
Volume
2.38L
Upper Circuit
₹173.16
Lower Circuit
₹115.44
Day's Low - High
₹143.11 - ₹146.9
52 Week Low - High
₹109.3 - ₹241

Sparc Historical Returns

1 Month Return
+ 0.48 %
3 Month Return
-8.28 %
1 Year Return
-34.33 %
3 Year Return
-34.44 %
5 Year Return
-19.52 %

Sparc Fundamentals

as on September 18, 2025 at 3:17 pm IST

Market Cap

₹4,682.85 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

-15.68

Return on capital employed (ROCE)

0

Industry PE ratio

42.21

Beta (LTM)

1.38

P/B Ratio

-21.76

Dividend Yield

0

PEG Ratio

-5.7

Quarterly Earnings Growth YOY

-45.91

EPS (TTM)

-10.55

Sector

Pharmaceuticals

Book Value

-6.68

Technical Analysis

Sparc Stock Valuation

as on September 18, 2025 at 3:17 pm IST

Sparc in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-15.68x)

September 17, 2025

Industry (42.21x)

September 17, 2025

Highest (0.00x)

December 29, 2023

LowHigh

Today’s Price to Earnings Ratio: -15.68x

Sun Pharma Advanced Research Company Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sparc with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
NA4,682.85-3.9%1.88-34371
BUY36,969.3829.99%0.682641,197
BUY17,696.6412.03%0.718367,234
BUY14,797.1744.73%0.672441,515
HOLD20,230.6960.61%0.533381,669

Sparc Stock's Interest Amongst Investors

Search interest for Sun Pharma Advanced Research Company Ltd Stock has increased by 14% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:14% versus previous 30 day period

Sun Pharma Advanced Research Company Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sales
47.69
23.95
21.18
13.86
16.56
16.81
12.86
14.91
27.19
9.64
Other Income
10.73
10.19
8.49
6.39
4.4
1.56
0.04
0.19
-
9.14
Total Income
58.42
34.14
29.67
20.25
20.96
18.37
12.9
15.1
27.19
18.78
Expenses
137.26
126.13
112.65
116.48
122.39
110.17
115.77
88.6
80.37
61.72
Operating Profit
-89.57
-102.18
-91.47
-102.62
-105.83
-93.36
-102.91
-73.69
-53.18
-52.08
Operating Profit Margin %
-187.82%
-426.64%
-431.87%
-740.4%
-639.07%
-555.38%
-800.23%
-494.23%
-195.59%
-540.25%
Profit Before Interest, Tax and Depreciation
-78.84
-91.99
-82.98
-96.23
-101.43
-91.8
-102.87
-73.5
-53.18
-42.94
Interest
0.21
0.26
0.26
0.26
0.91
0.56
1.14
2.8
4.54
6.19
Depreciation
2.94
3.1
3.18
3.16
3.07
3.14
3.16
3.14
2.95
2.68
Profit Before Tax
-81.99
-95.35
-86.42
-99.65
-105.41
-95.5
-107.17
-79.44
-60.67
-51.81
Tax Paid
-
-
-
-
0.38
0.4
0.16
0.07
-0.9
0.06
Profit After Tax
-81.99
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
Total Net profit including share of profit / Loss from associate company
-81.99
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
Actual EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
Adjusted EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
Diluted EPS
-2.55
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6

Sun Pharma Advanced Research Company Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Sales
238.78
75.55
71.77
Other Income
10.88
29.47
1.79
Total Income
249.66
105.02
73.56
Expenses
452.84
477.65
394.91
Operating Profit
-214.06
-402.1
-323.14
Operating Profit Margin %
-89.65%
-532.23%
-450.24%
Profit Before Interest, Tax and Depreciation
-203.18
-372.63
-321.35
Interest
7.63
1.69
9.04
Depreciation
11.77
12.51
12.39
Profit Before Tax
-222.58
-386.83
-342.78
Tax Paid
-
0.38
-0.27
Profit After Tax
-222.58
-387.21
-342.51
Total Net profit including share of profit / Loss from associate company
-222.58
-387.21
-342.51
EPS
-7.82
-11.93
-10.55
Actual EPS
-7.82
-11.93
-10.55
Adjusted EPS
-7.82
-11.93
-10.55
Diluted EPS
-7.82
-11.93
-10.55

Sun Pharma Advanced Research Company Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-69.12
-429.19
-360.29
Cash Flow from Investing Activities
-548.28
391.53
157.67
Cash Flow from Financing Activities
616.75
42.41
199.25
Net Cash Flow
-0.64
4.75
-3.37

Sparc Stock Shareholding Pattern

Numbers in percentages

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Promoters
68.22%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
DII
0.93%
0.78%
0.78%
0.23%
0.81%
0.82%
0.18%
0.23%
0.64%
1.13%
0.97%
FII
0%
0%
0%
0%
3.3%
3.23%
2.64%
2.15%
2.23%
1.45%
1.47%
Public
27.37%
29.91%
29.91%
29.86%
30.21%
30.28%
31.51%
31.95%
31.46%
31.75%
31.88%
Total Outstanding Shares
27,53,29,467
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
Total Shareholders
96,337
98,777
1,00,807
1,01,433
1,03,990
1,02,743
1,25,184
1,28,205
1,31,034
1,42,864
1,40,724

Sparc Earnings and Dividends

View detailed summary of the earnings and dividend history of Sparc.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 45.91% since last year same period to ₹-51.87Cr in the Q1 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 13.22% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sparc Stock

Check stock indices that include Sparc.

BSE Small-Cap

₹54,513.53

-0.04 (-23.5%)

BSE Healthcare

₹45,134.03

0.88 (395.3%)

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.75% to 31.88% in Jun 2025 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 1.45% to 1.47% in Jun 2025 quarter

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Jun 2025 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 45.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 174.1%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, SPARC stock has moved down by -34.4%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 1.01% to 0.94% in Jun 2025 quarter

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹9.64Cr as on June 2025 (Q1 FY26)
Net Profit: ₹-51.87Cr as on June 2025 (Q1 FY26)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODilip S Shanghvi
E-voting on sharesClick here to vote

FAQs

What is Sparc share price today?

Sparc share price today stands at ₹144.25 as on at the close of the market. Sparc share today touched a day high of ₹146.9 and a low of ₹143.11.

What is the 52 week high and 52 week low range for Sparc share?

Sparc touched a 52 week high of ₹241 and a 52 week low of ₹109.3. Sparc share price today i.e. is closed at ₹144.25, which is -40.15% down from its 52 week high and 31.98% up from its 52 week low.

What is Sparc's market capitalisation today?

Sparc market capitalisation is ₹4,682.85 Cr as on .

How to buy Sparc shares?

To buy Sparc shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SPARC or Sun Pharma Advanced Research Company Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sparc shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sparc trading volume today?

Sparc trading volume is 2.38L as on . This means that 2.38L shares of Sparc were bought and sold on the stock market during today's trading session.